STEP.TO(STEP.TO)
STEP.TO
No analyst ratings available
No analyst price targets available for STEP.TO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $927M | $946M | $767M | $761M |
| Low | $927M | $904M | $767M | $761M |
| High | $927M | $987M | $767M | $761M |
| EBITDA Avg | $95M | $97M | $79M | $78M |
| Low | $95M | $93M | $79M | $78M |
| High | $95M | $102M | $79M | $78M |
| EBIT Avg | $-26M | $-27M | $-22M | $-21M |
| Low | $-26M | $-28M | $-22M | $-21M |
| High | $-26M | $-25M | $-22M | $-21M |
| Net Income Avg | $23M | $30M | $48M | $48M |
| Low | $23M | $27M | $48M | $48M |
| High | $23M | $37M | $48M | $48M |
| EPS Avg | $0.31 | $0.43 | $0.65 | $0.64 |
| Low | $0.31 | $0.37 | $0.65 | $0.64 |
| High | $0.31 | $0.49 | $0.65 | $0.64 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $244M | $170M | $287M | $218M | $186M | $302M |
| Low | $244M | $170M | $287M | $218M | $186M | $302M |
| High | $244M | $170M | $287M | $218M | $186M | $302M |
| EBITDA Avg | $25M | $17M | $30M | $22M | $19M | $31M |
| Low | $25M | $17M | $30M | $22M | $19M | $31M |
| High | $25M | $17M | $30M | $22M | $19M | $31M |
| EBIT Avg | $-7M | $-5M | $-8M | $-6M | $-5M | $-8M |
| Low | $-7M | $-5M | $-8M | $-6M | $-5M | $-8M |
| High | $-7M | $-5M | $-8M | $-6M | $-5M | $-8M |
| Net Income Avg | $7M | $7M | $19M | $7M | $6M | $13M |
| Low | $7M | $7M | $19M | $7M | $6M | $13M |
| High | $7M | $7M | $19M | $7M | $6M | $13M |
| EPS Avg | $0.09 | $0.10 | $0.26 | $0.09 | $0.08 | $0.17 |
| Low | $0.09 | $0.10 | $0.26 | $0.09 | $0.08 | $0.17 |
| High | $0.09 | $0.10 | $0.26 | $0.09 | $0.08 | $0.17 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |